Eugene ENT: "Requests YTN Approval Revocation Process Be Put on Hold Until After Court Ruling"

Eugene ENT Sends Commission Letter Asking It to Put Approval Revocation Process on Hold
Seoul High Court Sets December 18 for Appellate Ruling

Eugene ENT said on October 30 that it had asked the Broadcasting Media and Communications Commission to postpone the procedure to revoke approval of the change in YTN's largest shareholder, scheduled for next month, until after the appellate court ruling.

The Seoul High Court concluded arguments in the appeal over the revocation of the approval for the change in YTN's largest shareholder on October 30 and set December 18 at 2 p.m. as the date for its ruling.

On November 28 last year, the Seoul Administrative Court revoked the approval, ruling that a decision made by the two-member Korea Communications Commission was unlawful. Eugene ENT appealed as an assisting intervenor.

The Broadcasting Media and Communications Commission began reviewing the revocation of the approval in response to that ruling. The first ground for revocation being considered in the ongoing hearing is also whether the decision by the two-member Korea Communications Commission was unlawful. The hearing and other steps in the revocation procedure were scheduled for November 3, and Eugene ENT has asked the commission to put them on hold.

In an official letter to the commission, Eugene ENT said, "With an appellate court ruling on the same issue expected in about seven weeks, proceeding with the approval revocation process beforehand could result in conflicting decisions by the administrative authority and the court. It could also affect our opportunity to obtain a judicial ruling from the higher court."

It added, "Because the approval revocation process is not subject to a deadline, it is difficult to identify any public interest that would be harmed by postponing the process for about seven weeks. By contrast, proceeding after the court has ruled would further strengthen the legitimacy of the conclusion and legal certainty."

On October 28, Eugene ENT had also asked to change the hearing date through its legal representatives, citing insufficient time to review the materials.

A Eugene ENT official said, "Respecting the court's decision and proceeding with subsequent steps based on its ruling is a reasonable course of action for both the commission and our company. Regardless of whether the process is put on hold, we will faithfully meet the conditions for the approval and fully cooperate with the commission's proceedings."

This content was produced with the assistance of AI translation services.